Cargando…

RIPK1 in Liver Parenchymal Cells Limits Murine Hepatitis during Acute CCl(4)-Induced Liver Injury

Some life-threatening acute hepatitis originates from drug-induced liver injury (DILI). Carbon tetrachloride (CCl(4))-induced acute liver injury in mice is the widely used model of choice to study acute DILI, which pathogenesis involves a complex interplay of oxidative stress, necrosis, and apoptosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hameed, Huma, Farooq, Muhammad, Vuillier, Céline, Piquet-Pellorce, Claire, Hamon, Annaïg, Dimanche-Boitrel, Marie-Thérèse, Samson, Michel, Le Seyec, Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266426/ https://www.ncbi.nlm.nih.gov/pubmed/35806372 http://dx.doi.org/10.3390/ijms23137367

Ejemplares similares

Switching to Regular Diet Partially Resolves Liver Fibrosis Induced by High-Fat, High-Cholesterol Diet in Mice
por: Farooq, Muhammad, et al.
Publicado: (2022)

Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
por: Farooq, Muhammad, et al.
Publicado: (2019)

RIPK1 protects hepatocytes from death in Fas-induced hepatitis
por: Filliol, Aveline, et al.
Publicado: (2017)

RIPK1 protects from TNF-α-mediated liver damage during hepatitis
por: Filliol, Aveline, et al.
Publicado: (2016)

Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response
por: Simoes Eugénio, Mélanie, et al.
Publicado: (2020)

Endogenous IL-33 Deficiency Exacerbates Liver Injury and Increases Hepatic Influx of Neutrophils in Acute Murine Viral Hepatitis
por: Carrière, Virginie, et al.
Publicado: (2017)

Toll‐like receptor‐2 exacerbates murine acute viral hepatitis
por: Bleau, Christian, et al.
Publicado: (2016)

TRIM21, a New Component of the TRAIL-Induced Endogenous Necrosome Complex
por: Simoes Eugénio, Mélanie, et al.
Publicado: (2021)

Interleukin-33 overexpression is associated with liver fibrosis in mice and humans
por: Marvie, Pierrick, et al.
Publicado: (2010)

Listeriolysin O, but not Murine E-cadherin, is Involved in Invasion of Listeria monocytogenes into Murine Liver Parenchymal Cells
por: Kanayama, Yu-ju, et al.
Publicado: (2015)

Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
por: Weiskirchen, Ralf, et al.
Publicado: (2019)

All-In-One: Advanced preparation of Human Parenchymal and Non-Parenchymal Liver Cells
por: Werner, Melanie, et al.
Publicado: (2015)

Milk Fermented by Propionibacterium freudenreichii Induces Apoptosis of HGT-1 Human Gastric Cancer Cells
por: Cousin, Fabien J., et al.
Publicado: (2012)

The IL-33/ST2 Axis Is Associated with Human Visceral Leishmaniasis and Suppresses Th1 Responses in the Livers of BALB/c Mice Infected with Leishmania donovani
por: Rostan, Octavie, et al.
Publicado: (2013)

Endoscopic ultrasound guided liver biopsy for parenchymal liver disease
por: Shah, Aun Raza, et al.
Publicado: (2019)

An In Vitro Human Liver Model by iPSC-Derived Parenchymal and Non-parenchymal Cells
por: Koui, Yuta, et al.
Publicado: (2017)

Simple diameter measurement as predictor of liver volume and liver parenchymal disease
por: Seppelt, D., et al.
Publicado: (2022)

Enrichment Methods for Murine Liver Non-Parenchymal Cells Differentially Affect Their Immunophenotype and Responsiveness towards Stimulation
por: Medina-Montano, Carolina, et al.
Publicado: (2022)

Pathogenic Mouse Hepatitis Virus or Poly(I:C) Induce IL-33 in Hepatocytes in Murine Models of Hepatitis
por: Arshad, Muhammad Imran, et al.
Publicado: (2013)

Isolation and co-culture of rat parenchymal and non-parenchymal liver cells to evaluate cellular interactions and response
por: Bale, Shyam Sundhar, et al.
Publicado: (2016)

Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases
por: Volk, Andreas M., et al.
Publicado: (2016)

Experimental and Clinical Evaluation of Capsular and Parenchymal Total Liver Perfusion
por: Kotzampassi, Katerina, et al.
Publicado: (1992)

Parenchymal Cell Damage and Bile Duct Activity in the Precancerous Liver
por: Sutton, P. M.
Publicado: (1962)

CRYSTALLINE STRUCTURES IN THE MITOCHONDRIA OF NORMAL HUMAN LIVER PARENCHYMAL CELLS
por: Wills, E. J.
Publicado: (1965)

Imaging-guided Parenchymal Liver Biopsy: How We Do It
por: Vijayaraghavan, Gopal R, et al.
Publicado: (2011)

Human non-parenchymal liver cells for co-cultivation systems
por: Ghallab, Ahmed
Publicado: (2014)

3D reconstruction in complex parenchymal sparing liver surgery
por: Bonomi, Alessandro Michele, et al.
Publicado: (2023)

The effect of camel urine on islet morphology and CCL4-induced liver cirrhosis in rat
por: Al Neyadi, S, et al.
Publicado: (2012)

The role of RIPK1 mediated cell death in acute on chronic liver failure
por: Kondo, Takayuki, et al.
Publicado: (2021)

THE ENZYMATIC PREPARATION OF ISOLATED INTACT PARENCHYMAL CELLS FROM RAT LIVER
por: Howard, Roger B., et al.
Publicado: (1967)

BENZPYRENE HYDROXYLASE ACTIVITY IN ISOLATED PARENCHYMAL AND NONPARENCHYMAL CELLS OF RAT LIVER
por: Cantrell, Elroy, et al.
Publicado: (1972)

Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells
por: Magee, Nancy, et al.
Publicado: (2016)

Role of EUS-guided liver biopsy in benign parenchymal disease (with video)
por: Huang, Jason Y.
Publicado: (2018)

Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver
por: Wisse, Eddie, et al.
Publicado: (2021)

Nigratine as dual inhibitor of necroptosis and ferroptosis regulated cell death
por: Delehouzé, Claire, et al.
Publicado: (2022)

The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-based therapy in colorectal cancer
por: Cousin, Fabien J., et al.
Publicado: (2016)

Correction: The role of RIPK1 mediated cell death in acute on chronic liver failure
por: Kondo, Takayuki, et al.
Publicado: (2022)

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease
por: Afonso, Marta B., et al.
Publicado: (2023)

UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis
por: Zhang, Tao, et al.
Publicado: (2023)

Mettl14 mutation restrains liver regeneration by attenuating mitogens derived from non-parenchymal liver cells
por: Yang, Insook, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kmh735a31rep2qumiuretd30uq